
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Roles of mitochondria in liver cancer stem cells
Ching-Wen Chang, Jeng‐Fan Lo, Xin Wei Wang
Differentiation (2019) Vol. 107, pp. 35-41
Open Access | Times Cited: 30
Ching-Wen Chang, Jeng‐Fan Lo, Xin Wei Wang
Differentiation (2019) Vol. 107, pp. 35-41
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Mitochondria in cancer stem cells: Achilles heel or hard armor
Xiaoxia Zheng, Junjie Chen, Yibo Sun, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 8, pp. 708-727
Closed Access | Times Cited: 26
Xiaoxia Zheng, Junjie Chen, Yibo Sun, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 8, pp. 708-727
Closed Access | Times Cited: 26
Targeted Anti-Mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 35
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 35
Redox balance and autophagy regulation in cancer progression and their therapeutic perspective
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 26
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 26
The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia
Majd A. Al-Hamaly, Evelyn Winter, Jessica S. Blackburn
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Majd A. Al-Hamaly, Evelyn Winter, Jessica S. Blackburn
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells
Mingming Wu, Huayu Wang, Xiangxiang Wu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 467-480
Open Access
Mingming Wu, Huayu Wang, Xiangxiang Wu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 467-480
Open Access
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells
Xiaoxue Jiang, Libo Xing, Yingjie Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 310-323
Open Access | Times Cited: 38
Xiaoxue Jiang, Libo Xing, Yingjie Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 310-323
Open Access | Times Cited: 38
Mitochondrial metabolic reprogramming: An important player in liver cancer progression
Tianqiang Jin, Chao Wang, Yu Tian, et al.
Cancer Letters (2019) Vol. 470, pp. 197-203
Closed Access | Times Cited: 35
Tianqiang Jin, Chao Wang, Yu Tian, et al.
Cancer Letters (2019) Vol. 470, pp. 197-203
Closed Access | Times Cited: 35
Mitochondrial Dysfunction and Oxidative Stress in Liver Transplantation and Underlying Diseases: New Insights and Therapeutics
Shaojun Shi, Xuan Wang, Luc J. W. van der Laan, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. 2362-2373
Open Access | Times Cited: 28
Shaojun Shi, Xuan Wang, Luc J. W. van der Laan, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. 2362-2373
Open Access | Times Cited: 28
Superior cuproptotic efficacy of diethyldithiocarbamate-Cu4O3 nanoparticles over diethyldithiocarbamate-Cu2O nanoparticles in metastatic hepatocellular carcinoma
Marwa M. Abu‐Serie, Assem Barakat, Sherif Ramadan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Marwa M. Abu‐Serie, Assem Barakat, Sherif Ramadan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Mechanisms of toxicity caused by bisphenol analogs in human in vitro cell models
Rafia Afroze Rifa, Macarena Gisele Rojo, Ramón Lavado
Chemico-Biological Interactions (2025), pp. 111475-111475
Closed Access
Rafia Afroze Rifa, Macarena Gisele Rojo, Ramón Lavado
Chemico-Biological Interactions (2025), pp. 111475-111475
Closed Access
The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy
Doudou Liu, Zhiwei Sun, Ting Ye, et al.
FEBS Open Bio (2021) Vol. 11, Iss. 7, pp. 1997-2007
Open Access | Times Cited: 24
Doudou Liu, Zhiwei Sun, Ting Ye, et al.
FEBS Open Bio (2021) Vol. 11, Iss. 7, pp. 1997-2007
Open Access | Times Cited: 24
Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma
Manar A. Elhinnawi, Michael Ibrahim Boushra, Donia Mohamed Hussien, et al.
Stem Cell Reviews and Reports (2024)
Closed Access | Times Cited: 3
Manar A. Elhinnawi, Michael Ibrahim Boushra, Donia Mohamed Hussien, et al.
Stem Cell Reviews and Reports (2024)
Closed Access | Times Cited: 3
The cause of cancer: The unifying theory
Marie-Ange Majérus
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100034-100034
Open Access | Times Cited: 14
Marie-Ange Majérus
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100034-100034
Open Access | Times Cited: 14
Targeted Anti-mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Babak Behnam, Hassan Akbari, et al.
(2022)
Open Access | Times Cited: 12
Farzad Taghizadeh‐Hesary, Babak Behnam, Hassan Akbari, et al.
(2022)
Open Access | Times Cited: 12
Editorial: Understanding mitochondrial dynamics and metabolic plasticity in cancer stem cells: Recent advances in cancer treatment and potential therapeutic approaches
Pramod Darvin, Varun Sasidharan Nair
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Pramod Darvin, Varun Sasidharan Nair
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Evaluation of Tumorigenic Properties of MDA-MB-231 Cancer Stem Cells Cocultured with Telocytes and Telocyte-Derived Mitochondria Following miR-146a Inhibition
Sena Babadag, Özlem Altundag‐Erdogan, Yeliz Z. Akkaya‐Ulum, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 7, pp. 341-352
Closed Access | Times Cited: 1
Sena Babadag, Özlem Altundag‐Erdogan, Yeliz Z. Akkaya‐Ulum, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 7, pp. 341-352
Closed Access | Times Cited: 1
Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo
Xiao‐Qi Yu, Qiulin Yan, Shuai Shen, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105509-105509
Closed Access | Times Cited: 10
Xiao‐Qi Yu, Qiulin Yan, Shuai Shen, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105509-105509
Closed Access | Times Cited: 10
Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach
Huijie Lu, Qianlin Zhu
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 36, Iss. 10, pp. 837-849
Closed Access | Times Cited: 9
Huijie Lu, Qianlin Zhu
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 36, Iss. 10, pp. 837-849
Closed Access | Times Cited: 9
Cancer Stem-Like Phenotype of Mitochondria Dysfunctional Hep3B Hepatocellular Carcinoma Cell Line
Yu-Seon Han, Eui-Yeun Yi, Myeong-Eun Jegal, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1608-1608
Open Access | Times Cited: 8
Yu-Seon Han, Eui-Yeun Yi, Myeong-Eun Jegal, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1608-1608
Open Access | Times Cited: 8
Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4
Tao Si, Liyin Huang, Ting Liang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Tao Si, Liyin Huang, Ting Liang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer
Yunhui Xie, Huizhong Jiang
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Yunhui Xie, Huizhong Jiang
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting
Lixia Chen, Yitian He, Jinshuai Lan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117520-117520
Open Access
Lixia Chen, Yitian He, Jinshuai Lan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117520-117520
Open Access
Current status and new directions for hepatocellular carcinoma diagnosis
Jinqi Tu, Bo Wang, Xiaoming Wang, et al.
Liver Research (2024) Vol. 8, Iss. 4, pp. 218-236
Open Access
Jinqi Tu, Bo Wang, Xiaoming Wang, et al.
Liver Research (2024) Vol. 8, Iss. 4, pp. 218-236
Open Access
Amino acid deprivation in cancer cells with compensatory autophagy induction increases sensitivity to autophagy inhibitors
Takahito Fukui, Manami Yabumoto, Misuzu Nishida, et al.
Molecular & Cellular Oncology (2024) Vol. 11, Iss. 1
Open Access
Takahito Fukui, Manami Yabumoto, Misuzu Nishida, et al.
Molecular & Cellular Oncology (2024) Vol. 11, Iss. 1
Open Access
Inhibitory effect of protonic bis(5-amino-1,10-phenanthroline) on proliferation of hepatocellular carcinoma and its molecular mechanism
Zizhen Zhao, Chen Fu, Yuping Zhang, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 8, pp. 103982-103982
Open Access | Times Cited: 1
Zizhen Zhao, Chen Fu, Yuping Zhang, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 8, pp. 103982-103982
Open Access | Times Cited: 1